The onset of effects from immediate-release (IR) amphetamine and dextroamphetamine mixed salts is typically observed within a relatively short timeframe. Individuals generally notice the initial effects of the medication within 30 to 60 minutes of oral administration. This rapid absorption and subsequent action contribute to its utility in managing symptoms requiring prompt intervention.
Understanding the time it takes for this formulation to become effective is crucial for treatment planning and patient education. It allows for appropriate scheduling of doses to coincide with periods of heightened need, such as work or school. Historically, the development of immediate-release formulations aimed to provide quick relief from symptoms, contrasting with later extended-release versions that offer a more sustained effect.